FDG PET imaging of paragangliomas of the neck: comparison with MIBG SPET
- PMID: 8575489
- DOI: 10.1007/BF00801625
FDG PET imaging of paragangliomas of the neck: comparison with MIBG SPET
Abstract
Two patients with cervical paragangliomas underwent positron emission tomography (PET) with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG). There was marked tumor uptake and retention of FDG. Adjacent salivary gland accumulation of FDG was minimal, though quite prominent with meta-iodobenzylguanidine. FDG PET offers another potentially useful approach to functional imaging of these uncommon tumors, independent of the presence of specific amine uptake mechanisms or cell surface receptors required by other scintigraphic techniques.
Similar articles
-
Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.Radiology. 1996 Jun;199(3):743-50. doi: 10.1148/radiology.199.3.8637999. Radiology. 1996. PMID: 8637999 Clinical Trial.
-
Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG.Radiology. 1993 Mar;186(3):711-5. doi: 10.1148/radiology.186.3.8430179. Radiology. 1993. PMID: 8430179
-
PET hydroxyephedrine imaging of neuroblastoma.J Nucl Med. 1996 Jan;37(1):16-21. J Nucl Med. 1996. PMID: 8543986
-
Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?Eur J Nucl Med. 1997 Jun;24(6):691-705. doi: 10.1007/BF00841411. Eur J Nucl Med. 1997. PMID: 9169580 Review.
-
Myocardial F-18 fluorodeoxyglucose imaging by SPECT.Clin Nucl Med. 1995 Jun;20(6):486-90. doi: 10.1097/00003072-199506000-00002. Clin Nucl Med. 1995. PMID: 7648727 Review.
Cited by
-
Molecular imaging of neuroendocrine tumors.Semin Oncol. 2010 Dec;37(6):662-79. doi: 10.1053/j.seminoncol.2010.10.015. Semin Oncol. 2010. PMID: 21167384 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources